Compare Summit Therapeutics Inc (SMMT) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Stryker Corporation — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 11.7× Summit Therapeutics Inc's market cap, and Stryker Corporation pays a 1% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | SYK | |
|---|---|---|
Market Cap | $10.48B | $122.35B |
Sector | Health | Technology |
52-Week High | $29.32 | $403.53 |
52-Week Low | $13.05 | $282.58 |
Enterprise Value | $9.90B | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
